Global Healthcare CRO Market
对这份报告感兴趣?
立即获取免费样品!
A contract research organization (合同研究组织) is a company that provides support to the pharmaceutical, 生物技术, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biological assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and real world evidence. The global healthcare CRO market is anticipated to increase by USD 20.7 十亿直到 2029 年均增长 6.2 根据最新市场估计的百分比. Significant increase in drug and medical device R&D and increase in private biotechnology organizations are the major factors driving the growth of the healthcare CRO market.Significant increase in drug and medical device R&D and increase in private biotechnology organizations are the major factors driving the growth of the healthcare CRO market.
该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global healthcare CRO market. 它提供了对市场的定量分析,使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.
该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the stage, 服务类型, 最终用户, 和地区. The global market for healthcare CRO can be segmented by stage: 药物发现, 临床前, 临床. The clinical segment is estimated to account for the largest share of the global healthcare CRO market. Healthcare CRO market is further segmented by service type: bio-statistics, clinical monitoring, data management, investigator payments, 实验室, medical writing, patient and site recruitment, project management and clinical supply management, quality management/assurance, regulatory and medical affairs, technology services, 其他的. The clinical monitoring segment held the largest revenue share in 2022. 基于最终用户, the healthcare CRO market is segmented into: 制药 & 生物制药公司, 医疗器械公司, 其他的. 全球范围, the pharmaceutical & biopharmaceutical companies segment made up the largest share of the healthcare CRO market. 根据地区, the healthcare CRO market also can be divided into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. Asia-Pacific was the largest contributor to the global healthcare CRO market in 2022.
市场细分
By stage: 药物发现, 临床前, 临床
按服务类型: bio-statistics, clinical monitoring, data management, investigator payments, 实验室, medical writing, patient and site recruitment, project management and clinical supply management, quality management/assurance, regulatory and medical affairs, technology services, 其他的
按最终用户: 制药 & 生物制药公司, 医疗器械公司, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美
The market research report covers the analysis of key stake holders of the global healthcare CRO market. Some of the leading players profiled in the report include Aragen Life Sciences Ltd., 生物测定, 公司. (皇家飞利浦公司), Charles River Laboratories, 公司, CTI Clinical Trial and Consulting, 公司, Evotec A.G., ICON plc, 伊克维亚公司, Labcorp Drug Development Inc, Medidata Solutions, 公司, Medpace Holdings, 公司, PAREXEL International Corporation, Pharmaron Beijing Co., 有限公司, PPD, 公司, PSI CRO AG, SGS S.A., Syneos Health, 公司, Syngene International Limited, WuXi AppTec, 公司, 除其他外. 在这份报告中, 全面分析关键参与者及其策略,以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表
报告范围
• To analyze and forecast the market size of the global healthcare CRO market.
• To classify and forecast the global healthcare CRO market based on stage, 服务类型, 最终用户, 地区.
• To identify drivers and challenges for the global healthcare CRO market.
• 检查竞争性发展,例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global healthcare CRO market.
• To identify and analyze the profile of leading players operating in the global healthcare CRO market.
为什么选择这份报告
• Gain a reliable outlook of the global healthcare CRO market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.
目录
数字和表格
部分 1. 介绍
· 报告说明
· 研究目的
· 细分市场
· 报告考虑的年份
· 货币
· 主要目标受众
部分 2. 方法
部分 3. 执行摘要
部分 4. 市场概况
· 介绍
· 司机
· 限制
部分 5. MARKET BREAKDOWN BY STAGE
· Drug discovery
· Pre-clinical
· 临床
部分 6. 按服务类型进行市场细分
· Bio-statistics
· Clinical monitoring
· Data management
· Investigator payments
· 实验室
· Medical writing
· Patient and site recruitment
· Project management and clinical supply management
· Quality management/assurance
· Regulatory and medical affairs
· Technology services
· 其他的
部分 7. 按最终用户划分的市场细分
· 制药 & 生物制药公司
· Medical device companies
· 其他的
部分 8. 按地区划分的市场细分
· 北美
· 欧洲
· 亚太地区
· 事物 (中东和非洲)
· 拉美
部分 9. 重点企业
· Aragen Life Sciences Ltd.
·生物测定, 公司. (皇家飞利浦公司)
· Charles River Laboratories, 公司.
· CTI Clinical Trial and Consulting, 公司.
· Evotec A.G.
·图标Plc
·IQVIA INC.
· Labcorp Drug Development Inc
· Medidata Solutions, 公司.
· Medpace Holdings, 公司.
·Parexel International Corporation
· Pharmaron Beijing Co., 有限公司.
·PPD, 公司.
· PSI CRO AG
· SGS S.A.
· Syneos Health, 公司.
· Syngene International Limited
· WuXi AppTec, 公司.
*索取免费样品以获得完整的公司列表
免责声明
Aragen Life Sciences Ltd.
生物测定, 公司. (皇家飞利浦公司)
Charles River Laboratories, 公司.
CTI Clinical Trial and Consulting, 公司.
Evotec A.G.
ICON plc
IQVIA INC.
Labcorp Drug Development Inc
Medidata Solutions, 公司.
Medpace Holdings, 公司.
PAREXEL International Corporation
Pharmaron Beijing Co., 有限公司.
PPD, 公司.
PSI CRO AG
SGS S.A.
Syneos Health, 公司.
Syngene International Limited
WuXi AppTec, 公司.
报告属性 | 细节 |
---|---|
基准年 | 2022 |
预测年份 | 2023-2029 |
复合年增长率 (2023-2029) | 6.22% |
页数 | 90 |
行业参与者 | Aragen Life Sciences Ltd., BioTelemetry Inc. (皇家飞利浦公司), Charles River Laboratories Inc., CTI Clinical Trial and Consulting Inc., Evotec A.G., ICON plc, IQVA持有。, Labcorp Drug Development Inc, Medidata Solutions Inc., Medpace Holdings Inc., PAREXEL International Corporation, Pharmaron Beijing Co. 有限公司, PPD Inc., PSI CRO AG, SGS S.A., Syneos Health Inc., Syngene International Limited, Wuxi Apptec Inc. |
请填写我们的表格,我们会尽快回复您.